National Institutes of Health

Description

Purpose. The National Human Genome Research Institute (NHGRI) solicits Small Business Innovation Research (SBIR [R43/R44]) grant applications to develop novel technologies that will enable extremely low-cost, high quality DNA sequencing. The goal of this initiative is to reduce the cost of sequencing a mammalian-sized genome to approximately $1000. Applicants may propose to develop full-scale sequencing systems or to investigate challenges underlying key system components. Exploration of methods other than those currently being pursued as potential $1,000 genome technologies are encouraged. High-risk/high-payoff proposals are appropriate to achieve the goals of this FOA by approximately 2014. Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with FOAs of identical scientific scope, RFA-HG-10-012 and RFA-HG-10-013, which solicit applications under the R01 and R21 grant mechanisms. Funds Available and Anticipated Number of Awards. The estimated amount of funds available for support of 25 projects awarded as a result of this announcement is $2.5 million for fiscal year 2011. Future year amounts will depend on annual appropriations.

Who can apply

• Small businesses

Contact

NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV